Announced Thu, 28 Aug · 13:43 IST

Please refer attachment

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Emmessar Biotech & Nutrition Ltd has submitted copies of newspaper advertisements published for its 33rd Annual General Meeting to BSE. The AGM is scheduled for Friday, September 26, 2025, at 11:30 AM (with login starting at 10:30 AM) and will be held via Video Conferencing / Other Audio-Visual Means in line with MCA and SEBI circulars. The notices were published in The Free Press Journal (English) and Navashakti (Marathi) on August 27, 2025. The AGM will consider the audited financial statements for FY ended March 31, 2025, and shareholders will have e-voting and remote e-voting facilities through CDSL. The filing was signed by Priyanka Sharma, Company Secretary, on August 28, 2025.

Likely market impact

This is a routine regulatory filing to comply with Companies Act and SEBI disclosure requirements for AGM intimation. No material impact on shareholders or stock price is expected — shareholders only need to note the AGM date (September 26, 2025) and e-voting window for participating in the meeting and voting.